SBC Medical Group Holdings Incorporated announced its fourth quarter and full year 2025 financial results, reporting a 117% year-over-year increase in Q4 net income to $14 million and a 9% increase in full-year net income to $51 million, while revenues declined due to business restructuring and revised franchise fee arrangements.
Key takeaways
Q4 2025 EPS was $0.14, representing a 133% year-over-year increase
Full year 2025 net income attributable to SBC Medical Group was $51 million, a 9% year-over-year increase
Total revenues for full year 2025 were $174 million, a 15% year-over-year decrease
Number of franchise locations increased to 283 as of December 31, 2025, up 34 locations from year-end 2024
The company announced updates to its business strategy and capital policy on March 27, 2026
EBITDA for full year 2025 was $70 million, a 21% year-over-year decrease